Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

Despite high specificity, the tests show low sensitivity for early-stage cancers, necessitating further validation through ...

Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple ...

ID Solutions will produce and supply dPCR assays for use in non-clinical research on Qiagen's QIAcuity platforms.

When left out on the counter for too long, a loaf of bread grows mold. That mold is a common type of filamentous fungi, a ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

A 14-gene molecular assay may help identify early-stage non-squamous NSCLC patients who benefit from chemotherapy ...

A molecular test identified patients with high-risk early lung cancer who significantly benefitted from adjuvant chemotherapy ...

We chose the ADC Payload Selector and Clinical Positioning Suite modules as the first impactful applications to open, but we intend to make all assay types available to partners in the coming ...